Sign In
Buy XBI
$129.83
+2.07 (+1.62%)
At Close: Jun 03, 2026
McAdam LLC Sells 1,876 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)
03:38pm, Monday, 15'th Nov 2021 Transcript Daily
McAdam LLC reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 15.5% in the third quarter, Holdings Channel reports. The fund owned 10,246 shares of the exchange traded funds stock after selling 1,876 shares during the quarter. McAdam LLCs holdings in SPDR S&P Biotech ETF were worth $1,288,000 at the end of []
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Wells Fargo & Company MN
01:54pm, Sunday, 14'th Nov 2021 Dakota Financial News
Wells Fargo & Company MN grew its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 962,574 shares of the exchange traded funds stock after purchasing an additional 30,639 []
How Are Biotech ETFs Reacting to These Q3 Earnings Releases?
12:50am, Saturday, 06'th Nov 2021
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
07:39am, Thursday, 04'th Nov 2021
Smart Beta ETF report for XBI
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
07:40am, Friday, 29'th Oct 2021
Sector ETF report for XBI
Big call buying in S&P Biotech (XBI)
01:53pm, Thursday, 28'th Oct 2021
"Halftime Report" trader Jon Najarian spots unusual activity in the options market
Can Biotech ETFs Gain From Positive Booster Update?
05:24pm, Thursday, 21'st Oct 2021
In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.
Is the biotech sell-off a buying opportunity
06:11pm, Monday, 18'th Oct 2021
Jared Holz, Oppenheimer, on whether the dip in biotech is an opportunity for investors. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman and Jeff Mills.
ETFs All You Need For Portfolios
04:57pm, Friday, 24'th Sep 2021
Building a core satellite ETF portfolio can give investors the best of two worlds.
Buying This Beaten-Down ETF Could Double Your Money Over the Next 5 Years
05:52am, Thursday, 23'rd Sep 2021
It could perhaps deliver a much bigger gain than 100%.
Stocks to Correct 5-10% in 2021? Buy These ETFs
01:33am, Wednesday, 15'th Sep 2021
Some market watchers are raising concerns about overvaluation in the market. Investors can thus bet on these undervalued but top-ranked ETFs.
5 Top ETFs With Great Value & More Room for Growth
02:10pm, Thursday, 09'th Sep 2021
The S&P 500 has been in a great shape this year, calling for overvaluation concerns. Why not investing in ETFs that have underperformed the S&P 500, have a lower P/E and have a Buy rating.
XBI Now Offers An Excellent Long-Term Entry Point
08:33am, Tuesday, 07'th Sep 2021
XBI has recently closed above its 10 month moving average, indicating a buy signal.
Best ETF Areas for Placing Your Bets in September
07:05pm, Friday, 03'rd Sep 2021
Let's take a look at some ETF areas that can be good investment options for September.
Top ETF Stories of August
09:53am, Thursday, 02'nd Sep 2021
Taper talks, the Senate approval of the infrastructure bill, upbeat earnings, FDA Approval for Pfizer COVID-19 Vaccine and recovery of China ETFs were the key highlights of the broader global markets
